Tuning the Preference of Thiodigalactoside- and Lactosamine-Based Ligands to Galectin-3 over Galectin-1
Author
Summary, in English
Inhibitors for galectin-1 and -3 were synthesized from thiodigalactoside and lactosamine by derivatization of the galactose C3. Introduction of 4-phenyl-1H-1,2,3-triazol-1-yl substituents at the thiodigalactoside C3 by CuAAC, targeting arginine-arene interactions, increased the affinity to 13 nM but yielded little selectivity. The builder 4-(4-phenoxypheny1)-1H-1,2,3-triazol-1-yl substituent, however, increased the preference for galectin-3 over galectin-1 to more than 200-fold. Modeling showed more arginine-arene interactions for galectin-3 than for galectin-1. Introducing 4-phenoxyaryl groups on lactosamine had a similar effect.
Department/s
- Centre for Analysis and Synthesis
- Division of Microbiology, Immunology and Glycobiology - MIG
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publishing year
2013
Language
English
Pages
1350-1354
Publication/Series
Journal of Medicinal Chemistry
Volume
56
Issue
3
Document type
Journal article
Publisher
The American Chemical Society (ACS)
Topic
- Medicinal Chemistry
Status
Published
ISBN/ISSN/Other
- ISSN: 1520-4804